For example, in vitro studies have demonstrated that estrogen increases OPG production by osteoblasts,38 suggesting a link between estrogen withdrawal postmenopause and the development of osteoporosis due to increased OPG levels. Here, TNFRSF11B is linked to osteoporosis.